The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Furosemide Pinewood 40 mg Tablets

Pinewood Laboratories LtdPA0281/263/002

Main Information

Trade NameFurosemide Pinewood 40 mg Tablets
Active SubstancesFurosemide
Dosage FormTablet
Licence HolderPinewood Laboratories Ltd
Licence NumberPA0281/263/002

Group Information

ATC CodeC03CA01 furosemide


License statusAuthorised
Licence Issued20/10/2023
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back